What if you could tame stubborn high blood pressure with a quick, minimally invasive treatment? That’s the promise of renal denervation (RDN), a game-changer in medical innovation. This groundbreaking field offers new hope for those battling resistant hypertension, thanks to innovations from industry leaders like Medtronic and Boston Scientific.
Medtronic‘s Symplicity Spyral uses radiofrequency energy to disrupt hypertension-causing nerves, while Boston Scientific’s Vessix V2 promises quicker, simpler procedures making RDN more accessible.
In recent years, the RDN industry has focused on refining these technologies to enhance their effectiveness and safety. From advanced catheter designs to sophisticated imaging techniques, the goal is clear: to provide a reliable solution for those who haven’t found relief through traditional treatments, promising a new era of hypertension management.
This article delves into the patent landscape of the renal denervation industry, revealing the top companies, groundbreaking inventors, technology overview and research centers driving these advancements.
This analysis is based on published patent data from 2004-2021. Interested in the updated analysis?
What is the patent filing trend in the Renal Denervation Industry?
The chart below represents the patent filing trend within the Renal Denervation Industry from the year 2003 to 2020.
The table below provides the number of applications filed and the number of patents granted from the year 2010 to 2021.
Year | Applications Filed in Renal Denervation Industry | Patents Granted in Renal Denervation Industry |
2021 | – | 9 |
2020 | 3 | 70 |
2019 | 20 | 77 |
2018 | 39 | 53 |
2017 | 41 | 40 |
2016 | 50 | 37 |
2015 | 54 | 56 |
2014 | 119 | 31 |
2013 | 173 | 35 |
2012 | 173 | 12 |
2011 | 91 | 3 |
2010 | 68 | 1 |
Technology Overview of Renal Denervation Industry Patents
The technology analysis of patents related to Renal Denervation industry explores the diverse and evolving nature of innovations within the sector.
Evolution of Renal Denervation Industry: 2002 – 2020
The chart below showcases the technology through the years 2002 to 2020 for the Renal Denervation Industry.
Key companies filing patents in Renal Denervation Industry
The chart below showcases the leading 15 companies actively involved in research and development in Renal Denervation industry.
The renal denervation industry is ruled by top healthcare giants, highlighting a strong focus on innovation for treating resistant hypertension. Interestingly, companies like Philips, known for their expertise in electronics, are stepping in, blending advanced imaging and diagnostics with renal denervation. This exciting cross-sector collaboration promises to spark further breakthroughs and make these cutting-edge treatments more widely available.
Technology Overview
This analysis provides an insight into areas of focus and innovations of companies thereby offering comprehensive snapshot of their contributions to the dynamic landscape of Renal Denervation sector.
The table below shows the number of patents assigned to the leading 25 companies involved in the Renal Denervation industry.
Leading Companies | Patents |
Boston Scientific | 147 |
Medtronic | 125 |
St Jude Medical | 49 |
Shanghai Antong Medical Technology Co Ltd | 39 |
Terumo Corporation | 32 |
Philips | 22 |
Lepu Beijing Medical Equipment Co Ltd | 21 |
Shanghai Microport Electrophysiology Medical Technology Co Ltd | 19 |
Biosense Webster | 18 |
Shanghai Huida Medical Equipment Co Ltd | 13 |
Cardiac Pacemakers Inc | 12 |
Shenzhen Huitai Medical Equipment Co Ltd | 12 |
Lifetech Technology Shenzhen Co Ltd | 11 |
Recor Medical Inc | 10 |
Pythagoras Medical Ltd | 9 |
Abbott | 8 |
Covidien Lp | 8 |
Ablative Solutions Inc | 7 |
Hunan Yiweidi Medical Equipment Co Ltd | 6 |
Pacesetter Inc | 6 |
Volcano Corporation | 6 |
Foresight Enterprise Co Ltd | 6 |
Mercator Medsystems Inc | 6 |
Oscor Inc | 5 |
Goodman Co Ltd | 5 |
Who are the leading innovators in Renal Denervation Industry?
The table below shows the number of patents assigned to the top 25 inventors involved in innovations and technological advancements in the Renal Denervation industry.
Inventor Name | Patents |
Qin Jie | 38 |
Wang Li | 36 |
Sheng Weiwen | 33 |
Wang Guohui | 31 |
Jenson Mark L | 31 |
Sutermeister Derek C | 26 |
Willard Martin R | 20 |
Sun Yiyong | 19 |
Zarins Denise | 18 |
Kobayashi Junichi | 18 |
Zhu Ping | 17 |
Wang Zhen | 17 |
Lindquist Jeffrey S | 16 |
Anderson James M | 16 |
Clark Benjamin J | 16 |
Xu Youlong | 15 |
Liu Zongjun | 15 |
Tan Jiahong | 14 |
Smith Scott R | 14 |
Hastings Roger | 14 |
Wang Rongjun | 12 |
Van Der Horst Arjen | 12 |
Jing Zhengxin | 12 |
Hanson Cass A | 12 |
Haverkost Patrick A | 12 |
Which countries have the maximum patent filings in Renal Denervation Industry?
The chart below provides an overview of the patent filings in the Renal Denervation industry in various countries.
Where are the Research Centers of Renal Denervation Industry patents located?
The chart below represents the major research and development centers contributing towards innovations and technological advancements in the Renal Denervation industry.
Leading companies in USA filing patents in Renal Denervation Industry
The chart below depicts the distribution of patents owned by the 15 leading companies within United States of America involved in the Renal Denervation industry.
Technology Overview
The technological categorization of patents ranging from Catheter Characteristics, Catheter-related Challenges and Excessive or Incomplete Renal Denervation offers a comprehensive overview of United States of America’s contributions towards the Renal Denervation sector.
Leading companies in China filing patents in Renal Denervation Industry
The chart below depicts the distribution of patents owned by the 15 leading companies within China involved in the Renal Denervation industry.
Technology Overview
The technological categorization of patents ranging from Intravascular, Hypertension or High Blood Pressure and Purpose of Monitoring offers a comprehensive overview of China contributions towards the Renal Denervation sector.
Leading companies in Japan filing patents in Renal Denervation Industry
The chart below depicts the distribution of patents owned by the leading companies within Japan involved in the Renal Denervation industry.
In an unexpected twist, Kaneka Corporation, a leader in polymers and advanced materials, and Kyocera Corporation, known for ceramics and electronics, are shaking up Japan’s renal denervation industry. Kaneka’s material innovations are boosting the safety and effectiveness of medical devices, while Kyocera’s precision components are enhancing the accuracy and durability of renal denervation tools. This exciting cross-sector collaboration proves that innovation knows no boundaries, driving forward cutting-edge treatments for resistant hypertension.
Technology Overview
The technological categorization of patents ranging from Catheter-related Challenges, Invasive and Heart Failure offers a comprehensive overview of Japan’s contributions towards the Renal Denervation sector.
Feel free to reach out to us, and our team will get in touch with you!